Christopher Chang

473 total citations
11 papers, 123 citations indexed

About

Christopher Chang is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Christopher Chang has authored 11 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Christopher Chang's work include CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers) and CRISPR and Genetic Engineering (2 papers). Christopher Chang is often cited by papers focused on CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers) and CRISPR and Genetic Engineering (2 papers). Christopher Chang collaborates with scholars based in United States, France and China. Christopher Chang's co-authors include Kathy H.Y. Shair, Leizhen Wei, Li Lan, Angela To, L. Patrick Havlik, P T Mora, Jenny L. Anderson, Joseph J. Muldoon, Aravind Asokan and Vincent Allain and has published in prestigious journals such as Cell, Blood and Nature Biotechnology.

In The Last Decade

Christopher Chang

9 papers receiving 120 citations

Peers

Christopher Chang
Chiara Pirillo United Kingdom
Ida Negreiros Portugal
Jessica A. Mine United States
Evan Conaway United States
Margaux Saillard Switzerland
Kyle Potts Canada
Chiara Pirillo United Kingdom
Christopher Chang
Citations per year, relative to Christopher Chang Christopher Chang (= 1×) peers Chiara Pirillo

Countries citing papers authored by Christopher Chang

Since Specialization
Citations

This map shows the geographic impact of Christopher Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Chang more than expected).

Fields of papers citing papers by Christopher Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Chang. The network helps show where Christopher Chang may publish in the future.

Co-authorship network of co-authors of Christopher Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Chang. A scholar is included among the top collaborators of Christopher Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Chang. Christopher Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chang, Christopher, Vivasvan S. Vykunta, Lian Li, et al.. (2025). SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci. Nature Biotechnology. 43(12). 2043–2053.
2.
Nyberg, William A., Angela To, Gabriella C. Reeder, et al.. (2023). An evolved AAV variant enables efficient genetic engineering of murine T cells. Cell. 186(2). 446–460.e19. 53 indexed citations
3.
Chang, Christopher, et al.. (2023). Telephone-based social health screening by pharmacists in the nonadherent Medicare population. Journal of Managed Care & Specialty Pharmacy. 29(11). 1184–1192. 2 indexed citations
4.
Allain, Vincent, William A. Nyberg, Joseph Muldoon, et al.. (2023). Targeted Integration of a Chimeric Antigen Receptor in Key Selected Loci in Primary Natural Killer Cells. Blood. 142(Supplement 1). 4807–4807. 1 indexed citations
5.
Liu, Lisa Grossman, Christopher Chang, Joanne Dai, et al.. (2017). Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines. mSphere. 2(6). 8 indexed citations
6.
Chang, Christopher, et al.. (2015). Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge. Journal of Antimicrobial Chemotherapy. 71(3). 803–806. 9 indexed citations
8.
Chen, Ling, Zheng Xu, Christopher Chang, et al.. (2013). Allospecific CD8 T suppressor cells induced by multiple MLC stimulation or priming in the presence of ILT3.Fc have similar gene expression profiles. Human Immunology. 75(2). 190–196. 9 indexed citations
9.
Zha, Qinglin, Chi Zhang, Christopher Chang, et al.. (2013). Xiaoqinglong Granules as Add-On Therapy for Asthma: Latent Class Analysis of Symptom Predictors of Response. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 9 indexed citations
10.
Kunkel, David C., Mark Riddle, Christopher Chang, et al.. (2009). New Onset Gastroesophageal Reflux Disease After Acute Gastroenteritis: A Case of Post-Infectious GERD?. The American Journal of Gastroenterology. 104. S367–S367.
11.
Chang, Christopher, Jenny L. Anderson, R G Martin, & P T Mora. (1977). Expression of tumor-specific transplantation antigen in cell lines transformed by wild-type of tsA mutant simian virus 40. Journal of Virology. 22(2). 281–289. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026